Tregitope Takes a Step Toward the Clinic

Tregitope Takes a Step Toward the Clinic

EpiVax Signs First Commercial License for Tregitope Technology PROVIDENCE, R.I., April 25, 2017 – Providence-based biotechnology company EpiVax, Inc. (“EpiVax”) has licensed its novel immune-modulating technology to an undisclosed global...
5th Annual NTD/EID Workshop

5th Annual NTD/EID Workshop

5th Annual NTD/EID Computational Vaccinology Workshop May 15th – 19th, 2017 iCubed, 80 Washington Street  Providence RI, United States   The Institute for Immunology and Informatics (iCubed) will once again be hosting our training workshop in vaccine design for...
EpiVax at Bio Asia 2017

EpiVax at Bio Asia 2017

Lucky us! the 14th International Bio Asia Conference is scheduled for March 14-15, 2017 at the Grand Hyatt, Tokyo in Roppongi. It might be a bit early for cherry blossoms, but hope springs eternal! We will be arriving a bit early and staying a bit late. Please let us...